Trinity Report Highlights AI Gaps, LG and D&D Collaborate

Hi there,

Welcome to this week's edition of Life AI Weekly, where we delve into the latest advancements in healthcare and life sciences AI. This week, we spotlight several significant developments, starting with Icarus Medical securing $7.2 million to propel its AI-driven orthopedic bracing technology forward. Meanwhile, a report by 5W AI Communications highlights that academic medical centers are leading the way in AI rankings across the United States, surpassing HCA Healthcare in most states.

In other news, LG AI Research and D&D Pharmatech are joining forces to enhance drug discovery through AI, while Channel Robotics has raised $4.6 million to develop an AI-enabled endoscopic robotic platform. Additionally, Arbital Health has launched ATLAS, an AI tool designed to assist Accountable Care Organizations with financial strategies. Stay tuned as we explore these stories and more, including collaborations aimed at improving glaucoma care, breast surgery outcomes, and vaccine innovation.

Trinity Report Finds AI Adoption Gaps in Pharma

A report by Trinity's TGaS Advisors reveals that while generative AI is widely adopted in the pharmaceutical industry, many companies lack the governance and infrastructure needed to maximize its benefits. Read more

AI Rankings Favor Academic Medical Centers Over HCA Healthcare

A report by 5W AI Communications reveals that academic medical centers are ranked first by AI answer engines in 46 US states, while HCA Healthcare did not receive top recommendations. Read more

LG AI Research and D&D Pharmatech Collaborate on AI-Driven Drug Discovery

LG AI Research and D&D Pharmatech have announced a partnership to develop oral peptide drugs using AI technology, aiming to improve drug discovery for incurable diseases. Read more

Vali Health Secures $6 Million for AI in Home Care

Vali Health, a startup from San Francisco, has raised $6 million to improve its AI tools for home care agencies, aiming to automate workforce management and reduce open shifts. Read more

Cenevo Survey on AI Adoption in Life Sciences Labs

A survey by Cenevo reveals that AI adoption is widespread in life sciences labs, but only 5% are using AI agents in production. Privacy and data management concerns were noted by 58% of respondents. Read more

Workera Boosts Learning Velocity for Medical Device Firm

Workera has enabled a global medical device manufacturer to enhance its workforce learning speed, achieving a 42% proficiency gain in 13 days with over 800 participants. Read more

Channel Robotics Raises $4.6 Million for AI Endoscopic Robotics

Channel Robotics has secured $4.6 million in funding to develop an AI-enabled endoscopic robotic platform, with plans for FDA submission in 2027. Read more

Arbital Health Launches AI Tool for ACO Financial Strategy

On June 18, 2026, Arbital Health announced the launch of ATLAS, an AI tool to aid Accountable Care Organizations in financial strategy under the CMS LEAD Model. Read more

ZEISS and Envision Partner for AI-Driven Glaucoma Care

ZEISS Medical Technology and Envision Health Technologies have announced a collaboration to enhance glaucoma care using virtual reality testing. Read more

SpeechDx Advances AI for Alzheimer's Detection

A recent publication in Alzheimer's & Dementia discusses SpeechDx's development of AI tools aimed at early detection and risk assessment of Alzheimer's, focusing on scalable digital markers for personalized care. Read more

HistoIndex AI Shows Positive Results in Liver Fibrosis Trial

HistoIndex and D&D Pharmatech report positive Phase 2 trial results for zabopegdutide in treating liver fibrosis, using AI analysis of liver biopsy samples. Read more

XEOS Study Shows AI-Enhanced PET-CT Improves Breast Surgery Outcomes

The BrIMA study by XEOS, published in JAMA Surgery, reveals that the AURA 10® PET-CT system improves the detection of positive margins in breast-conserving surgery, increasing intraoperative success rates significantly. Read more

Boltz Partners with Takeda for AI in Drug Discovery

Boltz has announced a collaboration with Takeda to utilize its biomolecular AI models for enhancing drug discovery processes. Read more

Co-Diagnostics and CoMira Launch AI Manufacturing Line in Saudi Arabia

Co-Diagnostics, Inc. has announced a new automated manufacturing line with CoMira Diagnostics in Saudi Arabia, aiming to boost diagnostic test production using AI technology. Read more

Capline Healthcare Cuts Claim Denials with AI

Capline Healthcare Management has reduced claim denials by 20% using AI-assisted claim scrubbing and improved billing services, achieving a 96% first-pass claim acceptance rate. Read more

AnHorn Medicines' AI Drug AH-008 Gets FDA and Taiwan Approvals

AnHorn Medicines has received FDA IND clearance and Taiwan CDE designation for its AI-driven drug AH-008, aimed at preventing chemotherapy-induced peripheral neuropathy. Read more

ChartSpan Acquires Validic for AI-Driven Healthcare

On June 22, 2026, ChartSpan announced its acquisition of Validic to enhance AI-driven remote patient monitoring and care management. Read more

Brenig Therapeutics Showcases AI-Designed NLRP3 Inhibitor

Brenig Therapeutics is presenting its AI-driven design of a brain-penetrant NLRP3 inhibitor, BT-409, at the Keystone Symposia. The presentation will focus on its potential to treat neuroinflammation in Parkinson's disease. Read more

TrueLab and Bionyra Sign $985 Million Licensing Deal

TrueLab Biopharmaceutical has entered a licensing agreement with Bionyra Pharma for AI-driven antibody development, potentially earning up to $985 million. Read more

Tredence Acquires KMK Consulting to Boost AI in Healthcare

Tredence has acquired KMK Consulting to enhance its AI capabilities in the Healthcare and Life Sciences sectors. The acquisition aims to increase Tredence's revenue from these sectors to 25% by 2028. Read more

ChemT Biotechnology Raises $5 Million for AI in Biomanufacturing

ChemT Biotechnology has secured $5 million in funding to enhance its AI-driven biomanufacturing infrastructure, focusing on the CelMo™ platform to improve manufacturing processes for advanced medicines. Read more

Insilico and SK Biopharmaceuticals Partner for AI Drug Discovery

Insilico Medicine and SK Biopharmaceuticals have formed a partnership valued at up to $2.5 billion to develop AI-driven drug candidates for neuroimmune disorders, utilizing Insilico's Pharma.AI platform and SK's clinical expertise. Read more

Coreline Soft and Mint Medical Partner for AI Lung Cancer Screening

On June 18, 2026, Coreline Soft and Mint Medical announced a partnership to enhance AI-enabled lung cancer screening by integrating their platforms, initially focusing on Germany with plans for international expansion. Read more

Icarus Medical Raises $7.2 Million for Orthopedic Tech

Icarus Medical has raised $7.2 million in a Series A funding round to advance its AI-driven orthopedic bracing technology, focusing on commercialization and clinical validation. Read more

Lunai Bioworks Secures U.S. Defense Contract

Lunai Bioworks has obtained a defense contract with the U.S. government for chemical threat assessment using its AI platform. The company is also advancing its neurology initiatives for conditions like epilepsy and Alzheimer's. Read more

DropGenie Secures Seed+ Funding for Gene Editing

DropGenie has completed its Seed+ financing round, led by Skeleton Key, to advance its AI-driven gene editing platform. Read more

Abu Dhabi DoH and Sanofi Collaborate on AI Vaccine Innovation

The Department of Health – Abu Dhabi and Sanofi have partnered to enhance vaccine innovation through AI, including establishing a Vaccine Innovation Centre in Abu Dhabi. Read more

Categories

Companies

Resources

Trinity Report Highlights AI Gaps, LG and D&D Collaborate - Life AI Weekly #73

We hope you enjoyed this article.

More from: Life Sciences

Subscribe to Life AI Weekly